IGHE and allergic disease: Although IgE blockade is a viable therapeutic approach for IgE-mediated allergies, the most widely prescribed treatment is omalizumab, whose efficacy is limited for patients with high lgE levels and safety is suboptimal due to its risk of anaphylaxis.